edecesertib (GS-5718) / Gilead  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
edecesertib (GS-5718) / Gilead
NCT04809623: Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

Terminated
1
3
US
Edecesertib, GS-5718, Placebo, Standard of Care
Gilead Sciences
Cutaneous Lupus Erythematosus
10/22
10/22

Download Options